» Articles » PMID: 38168846

Impact of COVID-19 Pandemic on Cord Blood Banking and Transplantation

Overview
Date 2024 Jan 3
PMID 38168846
Authors
Affiliations
Soon will be listed here.
Abstract

Umbilical cord blood is a rich source of hematopoietic stem cells that has been used for transplantation for over 30 years, especially when there is no compatible hematopoietic stem cell donor available. Its use has decreased more recently, since the development of methods to improve haploidentical transplants has allowed the use of mobilized peripheral blood as a source of hematopoietic stem cells. Public cord blood banks collect, process and store cord blood samples from voluntary donations. In addition, many public banks are involved in research to enhance hematopoietic stem cell therapies and develop new treatments for haematological and genetic diseases. The COVID-19 pandemic, which emerged in 2019, has had a profound and wide-ranging impact on human health and treatment. The area of hematopoietic stem cell transplantation was deeply affected by reductions in bone marrow, peripheral blood and cord blood donations; logistical challenges; exposure of healthcare workers and other challenges. The present study reviews the impact of the COVID-19 pandemic on cord blood banking and transportation around the world with a special focus on Brazil.

References
1.
Allan D, Green M, Morris G, Weiss J, Dibdin N, Mercer D . Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID-19 pandemic: A Canadian Blood Services Stem Cell Registry analysis. Vox Sang. 2022; 117(9):1121-1125. PMC: 9347538. DOI: 10.1111/vox.13294. View

2.
Anurogo D, Budi N, Thi Ngo M, Huang Y, Pawitan J . Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing. Int J Mol Sci. 2021; 22(12). PMC: 8230702. DOI: 10.3390/ijms22126275. View

3.
Cobo F, Stacey G, Hunt C, Cabrera C, Nieto A, Montes R . Microbiological control in stem cell banks: approaches to standardisation. Appl Microbiol Biotechnol. 2005; 68(4):456-66. PMC: 7080164. DOI: 10.1007/s00253-005-0062-2. View

4.
Damele L, Spaggiari G, Parodi M, Mingari M, Vitale M, Vitale C . Cord Blood-Derived Natural Killer Cell Exploitation in Immunotherapy Protocols: More Than a Promise?. Cancers (Basel). 2022; 14(18). PMC: 9496735. DOI: 10.3390/cancers14184439. View

5.
Zomer H, Girardi Goncalves A, Andrade J, Benedetti A, Trentin A . Lack of information about umbilical cord blood banking leads to decreased donation rates among Brazilian pregnant women. Cell Tissue Bank. 2021; 22(4):597-607. DOI: 10.1007/s10561-021-09903-1. View